Alzheimer's Disease

Showing NaN - NaN of 102

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alzheimer's Disease Trial in Worldwide (BIIB092, Placebo)

Terminated
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +100 more
Oct 18, 2022

Alzheimer's Disease Trial in Worldwide (PF-04360365 0.1 mg/kg, PF-04360365 0.5 mg/kg, PF-04360365 1 mg/kg)

Completed
  • Alzheimer's Disease
  • PF-04360365 0.1 mg/kg
  • +5 more
  • Peoria, Arizona
  • +41 more
Oct 11, 2022

Alzheimer's Disease Trial in Worldwide (Aducanumab)

Active, not recruiting
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +296 more
May 12, 2022

Alzheimer's Disease Trial in Worldwide (Gantenerumab, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +138 more
Dec 10, 2021

Agitation, Alzheimer's Disease Trial in United States (AVP-923-20, Placebo, AVP-923-30)

Completed
  • Agitation
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +43 more
Oct 29, 2021

Alzheimer's Disease Trial in Worldwide (ABBV-8E12)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +56 more
Nov 15, 2021

Alzheimer's Disease Trial in Worldwide (ALZT-OP1a, ALZT-OP1b, Placebo ALZT-OP1a)

Completed
  • Alzheimer's Disease
  • Gilbert, Arizona
  • +120 more
Nov 8, 2021

Cognitive Dysfunction, Alzheimer's Disease Trial in United States (Aducanumab, Placebo)

Terminated
  • Cognitive Dysfunction
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +21 more
Aug 19, 2021

Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

Terminated
  • Alzheimer's Disease
  • Aducanumab (BIIB037)
  • Placebo
  • Phoenix, Arizona
  • +180 more
Aug 9, 2021

Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

Terminated
  • Alzheimer's Disease
  • Aducanumab (BIIB037)
  • Placebo
  • Birmingham, Alabama
  • +179 more
Aug 9, 2021

Alzheimer's Disease Trial in United States (AC-1204, Placebo)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +81 more
Jul 30, 2021

Alzheimer's Disease Trial in Canada, United States (Azeliragon 5mg)

Terminated
  • Alzheimer's Disease
  • Azeliragon 5mg
  • Phoenix, Arizona
  • +70 more
May 28, 2021

Alzheimer's Disease Trial in Worldwide (Azeliragon, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +114 more
May 6, 2021

Agitation Associated With, Alzheimer's Disease, Alzheimer's Type Trial in Worldwide (Brexpiprazole, OPC-34712, Placebo Oral

Completed
  • Agitation Associated With
  • +4 more
  • Brexpiprazole, OPC-34712
  • Placebo Oral Tablet
  • Tuscaloosa, Alabama
  • +84 more
Dec 8, 2020

Alzheimer's Disease Trial in United States (SUVN-502, Placebo, Donepezil)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +70 more
Nov 20, 2020

Alzheimer's Disease Trial in Canada, United Kingdom, United States (Rosiglitazone, Placebo)

Completed
  • Alzheimer's Disease
  • Litchfield Park, Arizona
  • +14 more
Oct 27, 2020

Alzheimer's Disease Trial in United States (florbetapir F 18, Flortaucipir F18, Brain PET Scan)

Completed
  • Alzheimer's Disease
  • florbetapir F 18
  • +2 more
  • Phoenix, Arizona
  • +26 more
Sep 3, 2020

Alzheimer's Disease Trial in United States (Tricaprilin, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +24 more
Sep 18, 2020

Alzheimer's Disease, Traumatic Brain Injury, Depression Trial in United States (Flortaucipir F18, Brain PET scan)

Completed
  • Alzheimer's Disease
  • +2 more
  • Flortaucipir F18
  • Brain PET scan
  • Phoenix, Arizona
  • +4 more
Aug 21, 2020

Alzheimer's Disease Trial in Australia, United States (Flortaucipir F18, PET Scan)

Completed
  • Alzheimer's Disease
  • Flortaucipir F18
  • PET Scan
  • Phoenix, Arizona
  • +30 more
Sep 3, 2020

Alzheimer's Disease Trial in United States (Flortaucipir F18, PET Scan)

Completed
  • Alzheimer's Disease
  • Flortaucipir F18
  • PET Scan
  • Phoenix, Arizona
  • +21 more
Aug 7, 2020

Apathy, Alzheimer's Disease Trial in Canada, United States (Methylphenidate, Placebo)

Completed
  • Apathy
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +9 more
Aug 7, 2020

Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +195 more
Jul 1, 2020

Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia Trial in Worldwide (LMTM)

Terminated
  • Alzheimer's Disease
  • Behavioral Variant Frontotemporal Dementia
  • Phoenix, Arizona
  • +134 more
May 15, 2020

Amnestic Mild Cognitive Impairment, Alzheimer's Disease Trial in United States (Insulin (Humulin® R U-100), Placebo)

Completed
  • Amnestic Mild Cognitive Impairment
  • Alzheimer's Disease
  • Insulin (Humulin® R U-100)
  • Placebo
  • Phoenix, Arizona
  • +24 more
May 14, 2020